Compile Data Set for Download or QSAR
maximum 50k data
Found 20 of ph data with Target = 'Isoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)'
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204838(US9242977, 66-19)
Affinity DataIC50:  20nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204848(US9242977, 85-117)
Affinity DataIC50:  20nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204845(US9242977, 72-7)
Affinity DataIC50:  30nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204835(US9242977, 57)
Affinity DataIC50:  30nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204842(US9242977, 71)
Affinity DataIC50:  30nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204834(US9242977, 54)
Affinity DataIC50:  40nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204833(US9242977, 50)
Affinity DataIC50:  40nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204841(US9242977, 66-72)
Affinity DataIC50:  50nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204843(US9242977, 72-1)
Affinity DataIC50:  50nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204844(US9242977, 72-3)
Affinity DataIC50:  60nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204846(US9242977, 80-2)
Affinity DataIC50:  70nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204837(US9242977, 65-1)
Affinity DataIC50:  80nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204840(US9242977, 66-28)
Affinity DataIC50:  80nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204830(US9242977, 23)
Affinity DataIC50:  90nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204847(US9242977, 84-41)
Affinity DataIC50:  90nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204832(US9242977, 48)
Affinity DataIC50:  120nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204839(US9242977, 66-27)
Affinity DataIC50:  130nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204829(US9242977, 9)
Affinity DataIC50:  160nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204831(US9242977, 34)
Affinity DataIC50:  180nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform TrkA-I of High affinity nerve growth factor receptor (TrkAI)(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM204836(US9242977, 59)
Affinity DataIC50:  190nMpH: 7.5Assay Description:TrkA-inhibiting activity was measured according to the following method using LanthaScreen kinase assay reagents (Invitrogen; Fluorescein-Poly GT, La...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent